KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBIT Margin (2016 - 2025)

Thermo Fisher Scientific's EBIT Margin history spans 17 years, with the latest figure at 18.46% for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 77.0% year-over-year to 18.46%, compared with a TTM value of 17.38% through Dec 2025, up 27.0%, and an annual FY2025 reading of 17.38%, up 27.0% over the prior year.
  • EBIT Margin for Q4 2025 was 18.46% at Thermo Fisher Scientific, up from 17.45% in the prior quarter.
  • The five-year high for EBIT Margin was 30.78% in Q2 2021, with the low at 14.59% in Q2 2023.
  • Average EBIT Margin over 5 years is 18.92%, with a median of 17.4% recorded in 2024.
  • Year-over-year, EBIT Margin surged 1624bps in 2021 and then tumbled -928bps in 2023.
  • Tracing TMO's EBIT Margin over 5 years: stood at 23.72% in 2021, then tumbled by -31bps to 16.25% in 2022, then increased by 5bps to 17.03% in 2023, then grew by 4bps to 17.69% in 2024, then rose by 4bps to 18.46% in 2025.
  • Per Business Quant, the three most recent readings for TMO's EBIT Margin are 18.46% (Q4 2025), 17.45% (Q3 2025), and 16.9% (Q2 2025).